Miranda-Verastegui, C., Tulliano, G., Gyorkos, T. W., Calderon, W., Rahme, E., Ward, B., . . . Matlashewski, G. (2009). First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony.
Citación estilo ChicagoMiranda-Verastegui, Cesar, GianFranco Tulliano, Theresa W. Gyorkos, Wessmark Calderon, Elham Rahme, Brian Ward, Maria Cruz, Alejandro Llanos Cuentas, y Greg Matlashewski. First-line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination With Pentavalent Antimony. 2009.
Cita MLAMiranda-Verastegui, Cesar, et al. First-line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination With Pentavalent Antimony. 2009.
